EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

The slowdown of new infections by human retroviruses has reached a plateau in Spain

Carmen de Mendoza iD, Paula Carrizo, Silvia Sauleda, Alberto Richart, Ariadna Rando, Elisenda Miró, Rafael Benito, Oscar Ayerdi, Begoña Encinas, Antonio Aguilera, Gabriel Reina, Silvia Rojo und 9 weitere

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.28779 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Carmen de Mendoza und 20 weiteren Autor:innen. Beteiligte Einrichtung: Puerta de Hierro University Hospital & Research Foundation-IDIPHISA, Madrid, Spain. Hauptthemen laut MEDLINE: HIV Infections, HIV Seropositivity, Human T-lymphotropic virus 1, HIV-1. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 2022 annual meeting of the HTLV & HIV‐2 Spanish Network was held in Madrid on December 14. We summarize here the main information presented and discussed at the workshop and review time trends for human retroviral infections in Spain. As transmissible agents, infections by human retroviruses are of obligatory declaration. Until the end of 2022, the Spanish national registry had recorded 451 cases of HTLV‐1, 821 of HTLV‐2, and 416 of HIV‐2. For HIV‐1, estimates are of 150 000 people currently living with HIV‐1 and 60 000 cumulative deaths due to AIDS. During year 2022, new diagnoses in Spain were of 22 for HTLV‐1, 6 for HTLV‐2, and 7 for HIV‐2. The last updated figures for HIV‐1 are from 2021 and counted 2786 new diagnoses. The slowdown in yearly infections for HIV‐1 in Spain points out that new strategies are needed to achieve the United Nations 95‐95‐95 targets by 2025. For the remaining neglected human retroviral infections, their control might be pushed throughout four interventions: (1) expanding testing; (2) improving education and interventions aimed to reduce risk behaviors; (3) facilitating access to antiretrovirals as treatment and prevention, including further development of long‐acting formulations; and (4) increasing vaccine research efforts. Spain is a 47 million population country in South Europe with strong migration flows from HTLV‐1 endemic regions in Latin America and Sub‐Saharan Africa. At this time universal HTLV screening has been implemented only in the transplantation setting, following the report of 5 cases of HTLV‐associated myelopathy shortly after transplantation of organs from HTLV‐1 positive donors. There are four target populations for expanding testing and unveiling asymptomatic carriers responsible for silent HTLV‐1 transmissions: (1) migrants; (2) individuals with sexually transmitted infections; (3) pregnant women; and (4) blood donors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHIV SeropositivityHuman T-lymphotropic virus 1HIV-1HTLV-I InfectionsHumansFemalePregnancySpainHuman T-lymphotropic virus 2HIV-2

Stichwörter der Autor:innen

HIV-1HIV-2HTLV-1HTLV-2blood donorsepidemiologyhuman retrovirusesinterventionpregnant womenpreventionsexually transmitted infectionssurveillancetransfusiontransplantation

Autor:innen und Institutionen

  • Puerta de Hierro University Hospital & Research Foundation-IDIPHISA, Madrid, Spain.
  • Catalonian Tissue & Blood Bank, Barcelona, Spain.
  • Regional Transfusion Center, Madrid, Spain.
  • Vall d'Hebrón University Hospital, Barcelona, Spain.
  • Santa Creu i Sant Pau University Hospital, Barcelona, Spain.
  • Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.

ORCID-Profile: Carmen de Mendoza

Förderung

  • Instituto de Salud Carlos III

Zitieren

APA

de Mendoza, C., Carrizo, P., Sauleda, S., Richart, A., Rando, A., Miró, E., Benito, R., Ayerdi, O., Encinas, B., Aguilera, A., Reina, G., Rojo, S., González, R., Fernández-Ruiz, M., Liendo, P., Montiel, N., Roc, L., Treviño, A., Pozuelo, M. J., …, & HTLV Spanish Network (2023). The slowdown of new infections by human retroviruses has reached a plateau in Spain. Journal of Medical Virology. https://doi.org/10.1002/jmv.28779

Vancouver

de Mendoza C, Carrizo P, Sauleda S, Richart A, Rando A, Miró E, et al. The slowdown of new infections by human retroviruses has reached a plateau in Spain. Journal of Medical Virology. 2023. doi:10.1002/jmv.28779

BibTeX
@article{deMendoza2023,
  author = {de Mendoza, Carmen and Carrizo, Paula and Sauleda, Silvia and Richart, Alberto and Rando, Ariadna and Miró, Elisenda and Benito, Rafael and Ayerdi, Oscar and Encinas, Begoña and Aguilera, Antonio and Reina, Gabriel and Rojo, Silvia and González, Rocío and Fernández-Ruiz, Mario and Liendo, Paloma and Montiel, Natalia and Roc, Lourdes and Treviño, Ana and Pozuelo, María José and Soriano, Vicente and HTLV Spanish Network, HTLV Spanish Network},
  title = {The slowdown of new infections by human retroviruses has reached a plateau in Spain},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.28779}
}
Kostenlos starten →